.svg){kind=small}
Friday 10TH November, British Embassy TokyoWith support from the British Embassy Tokyo, Richmond Pharmacology will be holding an event to show how a dynamic, supportive and pragmatic regulatory and commercial environment, combined with cutting edge innovative study designs can help you drive your early stage clinical programs forward and maximise information obtained, supporting optimised global development.
-min.jpg)
.jpg)
Latest news
Richmond Appoints Lisa Campbell as Director of Regulatory Strategy
April 23, 2025
Richmond Pharmacology is pleased to announce the appointment of Lisa Campbell as Director of Regulatory Strategy
Read moreVon Willebrand Disease – First Stage of Hemab Therapeutics’ Trial Completed and New Patients Invited to Enrol
April 2, 2025
Richmond has completed dosing the first cohort of patients in Velora Pioneer, a phase 1/2 clinical trial investigating Hemab...
Read moreEvents
Swiss Biotech Day 2025
5–6 May 2025
Richmond Pharmacology is pleased to confirm our participation at Swiss Biotech Day 2025
View event
